Dr Reddy’s Sees Tocilizumab Clear Phase I

Indian Firm’s Biosimilar Rival To Actemra/RoActemra Moves Into Phase III Trials

 
• By David Wallace
  
Dr Reddy's Magnifying Glass
Dr Reddy’s has successfully completed a Phase I study for tocilizumab • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products